From JANUVIA to MARIZEV (Omarigliptin), a once weekly DPP-4 inhibitor for the treatment of diabetes

被引：0
|
作者：
Weber, Ann [1 ]
机构：
[1] Kallyope Inc, New York, NY USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
15
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Handelsman, Yehuda
    Lauring, Brett
    Gantz, Ira
    Iredale, Carol
    O'Neill, Edward A.
    Wei, Ziwen
    Suryawanshi, Shailaja
    Kaufman, Keith D.
    Engel, Samuel S.
    Lai, Eseng
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (10) : 1861 - 1868
  • [42] Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Zerilli, Tina
    Pyon, Eunice Y.
    CLINICAL THERAPEUTICS, 2007, 29 (12) : 2614 - 2634
  • [43] Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Shubrook, Jay
    Colucci, Randall
    Guo, Aili
    Schwartz, Frank
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2011, 4 : 1 - 12
  • [44] Linagliptin: A New DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2011, 123 (04) : 46 - 53
  • [45] DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes
    Deacon, Carolyn F.
    Carr, Richard D.
    Holst, Jens J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1780 - 1794
  • [46] Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Tahrani, Abd A.
    Piya, Milan K.
    Barnett, Anthony H.
    ADVANCES IN THERAPY, 2009, 26 (03) : 249 - 262
  • [47] Does the Glucose-Lowering Action of Omarigliptin, a Weekly DPP-4 Inhibitor, Last over a Week in Japanese Type 2 Diabetic Patients?
    Taniguchi, Yukiko
    Onishi, Tetsuro
    Mori, Yutaka
    DIABETES, 2017, 66 : A325 - A325
  • [48] Comparison of Diurnal Glycemic Variability on Day 1 vs. Day 7 of Treatment with the Once-Weekly DPP-4 Inhibitor Trelagliptin
    Onishi, Tetsuro
    Taniguchi, Yukiko
    Mori, Yutaka
    DIABETES, 2016, 65 : A309 - A309
  • [49] Effect of MK-3102, a novel once-weekly DPP-4 inhibitor, over 12 weeks in patients with type 2 diabetes mellitus
    Gantz, I.
    Chen, M.
    Mirza, A.
    Suryawanshi, S.
    Davies, M. J.
    Goldstein, B. J.
    DIABETOLOGIA, 2012, 55 : S51 - S51
  • [50] Sitagliptin: A DPP-4 Inhibitor
    McDermaid, Karen
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 : 21 - 21
12345